betamethasone/dexchlorpheniramine maleate / Generic mfg. - LARVOL DELTA

KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP (clinicaltrials.gov) - P3 | N=510 | Completed | Sponsor: Julia Bielicki | Recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Mar 2024

Trial completion • Trial completion date • Infectious Disease • Pneumonia • Respiratory Diseases

KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP (clinicaltrials.gov) - P3 | N=700 | Recruiting | Sponsor: University Hospital, Basel, Switzerland | Trial primary completion date: Dec 2023 ➔ Apr 2024

Trial primary completion date • Infectious Disease • Pneumonia • Respiratory Diseases

Machine Learning Model for Classification of Predominantly Allergic and Non-Allergic Asthma among Pre-school Children with Asthma Hospitalization. (PubMed, J Asthma) - "Six machine learning models: random forest, extreme gradient boosting, support vector machines, adaptive boosting, extra tree classifier, and logistic regression were then trained and tested using 10-fold stratified cross-validation. Among all features, age, weight, C-reactive protein, eosinophilic granulocytes, oxygen saturation, pre-medication inhaled corticosteroid + long-acting beta2-agonist (PM-ICS + LABA), PM-other (other pre-medication), H-Pulmicort/celestamine (Pulmicort/celestamine during hospitalization), and H-azithromycin (azithromycin during hospitalization) were found to be highly important. The support vector machine approach with a linear kernel was able to diffrentiate between predominantly allergic asthma and non-allergic asthma with higher accuracy (77.8%), precision (0.81), with a true positive rate of 0.73 and a true negative rate of 0.81, a F1 score of 0.81, and a ROC-AUC score of 0.79. Logistic regression was found to be the second-best classifier..."

Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases • CRP

KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP (clinicaltrials.gov) - P3; N=700; Recruiting; Sponsor: University Hospital, Basel, Switzerland; Trial completion date: Jan 2024 ➔ Dec 2024; Trial primary completion date: May 2023 ➔ Dec 2023

Clinical • Trial completion date • Trial primary completion date • Infectious Disease • Pneumonia • Respiratory Diseases

KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP (clinicaltrials.gov) - P3; N=700; Recruiting; Sponsor: University Hospital, Basel, Switzerland; Trial completion date: Jul 2021 ➔ Jan 2024; Trial primary completion date: Jun 2021 ➔ May 2023

Clinical • Trial completion date • Trial primary completion date • Infectious Disease • Pneumonia • Respiratory Diseases

A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico (clinicaltrials.gov) - P=N/A; N=153; Completed; Sponsor: Bayer; Not yet recruiting ➔ Completed

Trial completion • Allergic Rhinitis • Immunology